Liberum Capital began coverage on shares of Cambian Group PLC (LON:CMBN) in a report released on Tuesday. The brokerage issued a buy rating and a GBX 224 ($2.95) price target on the health services provider’s stock.
Several other research firms also recently commented on CMBN. Numis Securities Ltd reaffirmed an add rating and issued a GBX 161 ($2.12) target price on shares of Cambian Group PLC in a research report on Wednesday, April 26th. J P Morgan Chase & Co reaffirmed a neutral rating and issued a GBX 139 ($1.83) target price on shares of Cambian Group PLC in a research report on Thursday, April 27th.
Shares of Cambian Group PLC (LON CMBN) traded up 3.66% during mid-day trading on Tuesday, hitting GBX 212.50. The stock had a trading volume of 165,281 shares. Cambian Group PLC has a 52 week low of GBX 55.28 and a 52 week high of GBX 213.25. The stock has a 50 day moving average of GBX 175.56 and a 200-day moving average of GBX 158.28. The stock’s market capitalization is GBX 384.58 million.
In other news, insider Saleem Asaria sold 350,000 shares of the company’s stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of GBX 163 ($2.15), for a total value of £570,500 ($752,539.24).
About Cambian Group PLC
Cambian Group plc is a provider of specialist behavioral health services for children in the United Kingdom. The Company’s children services include specialist education services, specialist residential care services, foster care services and specialist mental health services. Its schools provide support to children with Autism, Asperger’s Syndrome, severe learning disabilities, challenging behavior and complex needs.
Receive News & Ratings for Cambian Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambian Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.
